Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial
2018 ◽
Vol 19
(1)
◽
pp. 65-75
◽
Jeffrey A Jones
◽
Anthony R Mato
◽
William G Wierda
◽
Matthew S Davids
◽
Michael Choi
◽
...
2018 ◽
Vol 5
(4)
◽
pp. e170-e180
◽
Jennifer R Brown
◽
Mehdi Hamadani
◽
John Hayslip
◽
Ann Janssens
◽
Nina Wagner-Johnston
◽
...
2018 ◽
Vol 19
(9)
◽
pp. 1215-1228
◽
Paula Cramer
◽
Julia von Tresckow
◽
Jasmin Bahlo
◽
Sandra Robrecht
◽
Petra Langerbeins
◽
...
Varsha Gandhi
◽
Prithviraj Bose
2016 ◽
Vol 17
(6)
◽
pp. 768-778
◽
Stephan Stilgenbauer
◽
Barbara Eichhorst
◽
Johannes Schetelig
◽
Steven Coutre
◽
John F Seymour
◽
...
Matthew S Davids
◽
Benjamin L Lampson
◽
Svitlana Tyekucheva
◽
Zixu Wang
◽
Jessica C Lowney
◽
...
Scott Kaufmann
◽
Wei Meng
Jin-Hua Liang
◽
Li Wang
◽
Hua-Yuan Zhu
◽
Jun Qian
◽
Hui Liao
◽
...
Paula Cramer
◽
Julia V. Tresckow
◽
Sandra Robrecht
◽
Jasmin Bahlo
◽
Moritz Fürstenau
◽
...
Cornedine J de Gooijer
◽
Vincent van der Noort
◽
Jos A Stigt
◽
Paul Baas
◽
Bonne Biesma
◽
...